Cargando…
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity
[Image: see text] Lipopolysaccharide (LPS) mimicry leading to toll-like receptor 4 (TLR4) active compounds has been so far based mainly on reproducing the lipid A portion of LPS. Our work led to a series of structurally simplified synthetic TLR4 agonists in preclinical development as vaccine adjuvan...
Autores principales: | Romerio, Alessio, Franco, Ana Rita, Shadrick, Melanie, Shaik, Mohammed Monsoor, Artusa, Valentina, Italia, Alice, Lami, Federico, Demchenko, Alexei V., Peri, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552098/ https://www.ncbi.nlm.nih.gov/pubmed/37810727 http://dx.doi.org/10.1021/acsomega.3c05363 |
Ejemplares similares
-
Emerging Extracellular Molecular Targets for Innovative Pharmacological Approaches to Resistant Mtb Infection
por: Italia, Alice, et al.
Publicado: (2023) -
New Glucosamine-Based
TLR4 Agonists: Design, Synthesis,
Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants
por: Romerio, Alessio, et al.
Publicado: (2023) -
Cleaner synthesis of preclinically validated vaccine adjuvants
por: Romerio, Alessio, et al.
Publicado: (2023) -
Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview
por: Romerio, Alessio, et al.
Publicado: (2020) -
Intramolecular glycosylation
por: Jia, Xiao G, et al.
Publicado: (2017)